The European League Against Rheumatism (EULAR) issued new gout treatment guidelines this week, the first since 2006.
CPPD disease, once known as pseudogout, is underdiagnosed. A thorough analysis of synovial fluid can help improve outcomes, researchers say.
For patients with gout, new evidence suggests arhalofenate can be used to safely prevent flare-ups, as well as reduce serum levels.
In 2015, ACR and EULAR issued classification criteria for gout. The scoring system is summarized here in an easy to use format for physicians and patients.
Few gout patients know their serum urate goals, which researchers say could hinder their chances of reaching remission.
FDA approval of lesinurad for gout, in combination with an xanthine oxidase inhibitor, could spell relief for some gout patients.
A new study attempts to find consensus on a challenging problem: When is gout considered to be in remission?
Sleep apnea and gout have a lot in common: Both are associated with an increased level of uric acid and the incidence of gout.
Maintaining normal serum urate concentrations can prevent tophi formation in gout reducing cardiovascular risk factors.
The prevalence of gout in more affluent countries seems to be increasing in recent decades. Medications, co-morbidities, genetics and other risk factors are to blame.